Yiannis Papazoglou is one of only 40 people in the world with a mutation of the IRF2BPL gene. Foundation Aims to Help Patients With Rare Diseases—Even Before They’re Recognized The Undiagnosed ...

Sangeetha Venugopal, MD, is assistant professor of clinical medicine at the University of Miami Sylvester Comprehensive Cancer Center. Larry Luxner, senior correspondent for Rare Disease Advisor, ...

Close monitoring is vital for managing patients with SRH, a rare but significant complication of AAV. A 52-year-old man presented to the rheumatology department with a 2-week history of anorexia and ...

A prominent association was demonstrated between the lowest alpha-1 antitrypsin levels and asthma exacerbations. An analysis of DNA samples from individuals with severe asthma and a review of alpha-1 ...

Although plasmapheresis showed promise as a treatment to mitigate the risks for severe HDFN, the current study underscored the importance of close monitoring due to potential complications such as ...

Can Do MS provides free in-person, virtual, and on-demand programs on topics such as nutrition, exercise, MS symptoms, relationships, and employment. Treatment for multiple sclerosis includes much ...

Which of the statements below about the prognosis of chronic lymphocytic leukemia (CLL) are correct? Select one of the options for each question, then submit your answers to see how well you scored ...

Mast cell leukemia is a form of cancer that can present with both osteoblastic and osteolytic bone lesions. A 75-year-old woman presented with a 2-week history of nausea, vomiting, and diarrhea. The ...

The first-line treatment of osteoporosis in patients with SM is usually bisphosphonates, and the usual approach for secondary osteoporosis treating the underlying condition in order to improve bone ...

Over my 4 decades living with multiple sclerosis (MS), I’ve had dozens of magnetic resonance imaging (MRI) exams. Almost all of them were done using a contrast agent (often called a dye) containing ...

In the ECHELON-3 study, the brentuximab vedotin combination with lenalidomide and rituximab reduced mortality risk by 37% compared with placebo. Brentuximab vedotin (Adcetris®) has been approved by ...

Cord bilirubin higher than 1.9 mg/dL was a strong predictor of hemolysis in Rh-positive neonates born to Rh-negative mothers. Cord bilirubin measurement served as a reliable, noninvasive tool for ...